Momenta Pharmaceuticals Inc

CIK 1235010 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Momenta Pharmaceuticals Inc.

Recent SEC filings

FiledFormAccession number
Nov 10, 2020SC 13G/A0000315066-20-001893
Oct 13, 202015-12G0001193125-20-267996
Oct 1, 2020S-8 POS0001193125-20-261388
Oct 1, 202040001179110-20-010062
Oct 1, 2020S-8 POS0001193125-20-261413
Oct 1, 2020S-8 POS0001193125-20-261403
Oct 1, 202040001179110-20-010059
Oct 1, 2020POSASR0001193125-20-261341
Oct 1, 202040001179110-20-010058
Oct 1, 202040001179110-20-010061
Oct 1, 2020S-8 POS0001193125-20-261397
Oct 1, 202040001179110-20-010064
Oct 1, 2020S-8 POS0001193125-20-261399
Oct 1, 202025-NSE0001354457-20-000548
Oct 1, 202040001179110-20-010052
Oct 1, 202040001179110-20-010063
Oct 1, 2020S-8 POS0001193125-20-261379
Oct 1, 2020S-8 POS0001193125-20-261382
Oct 1, 2020S-8 POS0001193125-20-261409
Oct 1, 2020S-8 POS0001193125-20-261391
Oct 1, 202040001179110-20-010055
Oct 1, 2020S-8 POS0001193125-20-261393
Oct 1, 202040001179110-20-010051
Oct 1, 2020SC TO-T/A0001193125-20-260647
Oct 1, 20208-K0001193125-20-261321